{"entity":{"type":"insider","cik":"0001259856","url":"/insider/0001259856","json_url":"/insider/0001259856.json","name":"FAMBROUGH DOUGLAS","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":5,"first":"2014-02-20","last":"2021-08-10","span_basis":"filed_date"},"name_variants":[{"name":"FAMBROUGH DOUGLAS","source":"filing","n_filings":5,"first_seen":"2014-02-20","last_seen":"2021-08-10"}],"transactions":[{"id":4118842,"accession":"0001399529-21-000146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001399529-21-000146","line_url":"/filing/0001399529-21-000146#line-1","is_derivative":false,"issuer_cik":"0001259856","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001259856","owner_cik":"0001259856","owner_name":"FAMBROUGH DOUGLAS","owner_display_name":"FAMBROUGH DOUGLAS","owner_url":"/insider/0001259856","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":22.096,"price_display":"22.10","price_state":"stated","total_value":110480.0,"total_display":"110,480.00","total_whole":"110,480","shares_owned_after":43164.0,"shares_owned_after_display":"43,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-10","filed_date":"2021-08-10","scope":"insider"},{"id":3319520,"accession":"0000899243-20-023797","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-023797","line_url":"/filing/0000899243-20-023797#line-1","is_derivative":false,"issuer_cik":"0001259856","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001259856","owner_cik":"0001259856","owner_name":"FAMBROUGH DOUGLAS","owner_display_name":"FAMBROUGH DOUGLAS","owner_url":"/insider/0001259856","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":18.0597,"price_display":"18.06","price_state":"stated","total_value":180597.0,"total_display":"180,597.00","total_whole":"180,597","shares_owned_after":22300.0,"shares_owned_after_display":"22,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-01","scope":"insider"},{"id":8278611,"accession":"0000899243-19-029699","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-19-029699","line_url":"/filing/0000899243-19-029699","is_derivative":false,"issuer_cik":"0001259856","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001259856","owner_cik":"0001259856","owner_name":"FAMBROUGH DOUGLAS","owner_display_name":"FAMBROUGH DOUGLAS","owner_url":"/insider/0001259856","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":25.86982292,"price_display":"25.87","price_state":"stated","total_value":2069585.8336,"total_display":"2,069,585.83","total_whole":"2,069,586","shares_owned_after":13731.0,"shares_owned_after_display":"13,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-19","scope":"insider","n_lines":2},{"id":8278592,"accession":"0000899243-19-029699","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-029699","line_url":"/filing/0000899243-19-029699","is_derivative":false,"issuer_cik":"0001259856","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001259856","owner_cik":"0001259856","owner_name":"FAMBROUGH DOUGLAS","owner_display_name":"FAMBROUGH DOUGLAS","owner_url":"/insider/0001259856","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59021.0,"shares_display":"59,021","price_per_share":26.166029750427814,"price_display":"26.17","price_state":"stated","total_value":1544345.2419,"total_display":"1,544,345.24","total_whole":"1,544,345","shares_owned_after":14605.0,"shares_owned_after_display":"14,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-17","filed_date":"2019-12-19","scope":"insider","n_lines":2},{"id":2818803,"accession":"0000899243-16-033692","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-033692","line_url":"/filing/0000899243-16-033692#line-2","is_derivative":false,"issuer_cik":"0001259856","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001259856","owner_cik":"0001259856","owner_name":"FAMBROUGH DOUGLAS","owner_display_name":"FAMBROUGH DOUGLAS","owner_url":"/insider/0001259856","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16500.0,"shares_display":"16,500","price_per_share":3.63,"price_display":"3.63","price_state":"stated","total_value":59895.0,"total_display":"59,895.00","total_whole":"59,895","shares_owned_after":55579.0,"shares_owned_after_display":"55,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-15","filed_date":"2016-11-16","scope":"insider"},{"id":2818800,"accession":"0000899243-16-033692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-033692","line_url":"/filing/0000899243-16-033692#line-1","is_derivative":false,"issuer_cik":"0001259856","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001259856","owner_cik":"0001259856","owner_name":"FAMBROUGH DOUGLAS","owner_display_name":"FAMBROUGH DOUGLAS","owner_url":"/insider/0001259856","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16600.0,"shares_display":"16,600","price_per_share":3.78,"price_display":"3.78","price_state":"stated","total_value":62748.0,"total_display":"62,748.00","total_whole":"62,748","shares_owned_after":39079.0,"shares_owned_after_display":"39,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-14","filed_date":"2016-11-16","scope":"insider"},{"id":7088435,"accession":"0001209191-14-012279","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-012279","line_url":"/filing/0001209191-14-012279#line-2","is_derivative":false,"issuer_cik":"0001259856","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001259856","owner_cik":"0001259856","owner_name":"FAMBROUGH DOUGLAS","owner_display_name":"FAMBROUGH DOUGLAS","owner_url":"/insider/0001259856","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":17300.0,"shares_owned_after_display":"17,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-29","filed_date":"2014-02-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001399529","name":"Dicerna Pharmaceuticals Inc","url":"/issuer/0001399529","role":"Director, Officer (President and CEO)","n_filings":5,"first_seen":"2014-02-20","last_seen":"2021-08-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001259856","retrieved_at":"2026-08-26T03:29:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}